Ls. Palmer et al., TRANSRECTAL ELECTROSTIMULATION THERAPY FOR NEUROPATHIC BOWEL DYSFUNCTION IN CHILDREN WITH MYELOMENINGOCELE, The Journal of urology, 157(4), 1997, pp. 1449-1452
Purpose: We attempted to evaluate the efficacy of transrectal bowel st
imulation for neurogenic bowel dysfunction in children with myelodyspl
asia. Materials and Methods: Daily sessions of transrectal electrostim
ulation were performed on an outpatient basis for 2 to 3 weeks on chil
dren with myelodysplasia and stool incontinence. If benefits were note
d, 5 to 10 additional daily sessions were performed. Complete success
was defined as improvement in all parameters of interest, including de
crease in the frequency of daily bowel movements, increased sensation,
increased ability to hold stool and a significant subjective change i
n bowel habits. Moderate success implied improvement in 1 to 3 paramet
ers and treatment failure was defined as lack of improvement in any pa
rameter. Results: A total of 55 children 2 to 14 years old (mean age 6
.7) completed a mean of 18 daily sessions per patient of bowel electro
stimulation. Followup ranged from 1 to 6 years. Diapers are no longer
required due to defecation problems in 14 children older than 3 years.
Complete success was achieved in 20 cases (36.3%) and moderate succes
s in an additional 30 (54.5%, overall success rate 90.8%). Specificall
y, 89% of the patients reported elimination of stooling accidents, 82%
reported increased sensation and 71% were able to hold the bowel move
ment. Overall 68% of the patients noticed significantly improved bowel
function. Complete/moderate success of transrectal electrostimulation
was statistically significant for all 4 parameters (p <0.05), and com
plete success was significant for increased sensation, ability to hold
and episodes of accidents. Therapy failed in 5 children (9%). There w
ere no untoward effects. Conclusions: Transrectal electrostimulation i
s a well tolerated and minimally invasive modality that provides susta
inable improvement in stool continence in children with myelomeningoce
le and neuropathic bowel dysfunction.